NovoSeven RT

Coagulation factor viia (recombinant) · Novo Nordisk
PRESCRIPTION ONLY (USA)

NovoSeven RT ingredients

Active ingredientStrength
Coagulation factor viia (recombinant)see label

What NovoSeven RT is used for

NovoSeven RT is a specialist medicine. Its approved uses are listed on the official FDA label below.

Key facts

Brand
NovoSeven RT
Generic name
Coagulation factor viia (recombinant)
Made by
Novo Nordisk
Forms
Kit
FDA approval
Biologic licence (BLA) BLA103665
On the US market since
2008

Official information

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is NovoSeven RT?

NovoSeven RT (Coagulation factor viia (recombinant)) is a specialist medicine made by Novo Nordisk, approved by the US FDA.

What are the ingredients of NovoSeven RT?

NovoSeven RT contains Coagulation factor viia (recombinant).

From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.

← All specialty medicines, USA

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.